Opis działalności
Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. Neogen’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
Zarząd & Rada nadzorcza
| CEO |
| John Adent |
| Zarząd |
| David Naemura, Amy M. Rocklin, Dr. Jason W. Lilly, Dr. Robert S. Donofrio, Jerome Hagedorn, Julie L. Mann, Byoung-Ik Sohn, Matt Mittino |
| Rada nadzorcza |
| James C. Borel, Aashima Gupta, Catherine E. Woteki, James P. Tobin, Jeffrey Capello, Ralph A. Rodriguez, Ronald Green, William T. Boehm |
Dane firmy
| Nazwa: |
Neogen Corp. |
| Adres: |
620 Lesher Place,Lansing, Michigan 48912, USA |
| Telefon: |
+1-517-372-9200 |
| Fax: |
+1-517-372-2006 |
| E-mail: |
corporate@neogen.com
|
| Internet: |
www.neogen.com |
| Przemysł: |
Biotechnologia |
| Sektor: |
Biotechnologia |
| Podsektor: |
Biotechnologia |
| Koniec roku finansowego: |
31.05 |
| Free float: |
60,89% |
| Data IPO: |
- |
Relacje inwestorskie
| Nazwa: |
Steven J. Quinlan |
| Telefon: |
+1-517-372-2280 |
| Fax: |
- |
| E-mail: |
ir@neogen.com
|
